| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |